CONFLICT OF INTEREST STATEMENT James M. Metz reports travel fees from Proton Therapy, Inc and Varian Medical Systems, Inc. Mark O'Hara reports consulting fees from Alligator Bioscience, and Merus; and grant and/or contract funding from Arcus Bioscience, Bristol-Myers Squibb, Celldex Therapeutics, Elicio Therapeutics, Geistlich Pharma, North America, Inc, Genmab, HiberCell, Natera, Revolution Medicines, Stand Up To Cancer, and Verastem, Inc.